Impact Medical Limited 04172089 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is Operation of mobile lithotripsy Digita Accounts Production Advanced 6.30.9574.0 true 04172089 2024-04-01 2025-03-31 04172089 2025-03-31 04172089 bus:OrdinaryShareClass1 2025-03-31 04172089 core:RetainedEarningsAccumulatedLosses 2025-03-31 04172089 core:ShareCapital 2025-03-31 04172089 core:CurrentFinancialInstruments 2025-03-31 04172089 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 04172089 core:FurnitureFittingsToolsEquipment 2025-03-31 04172089 core:MotorVehicles 2025-03-31 04172089 bus:SmallEntities 2024-04-01 2025-03-31 04172089 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04172089 bus:FilletedAccounts 2024-04-01 2025-03-31 04172089 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04172089 bus:RegisteredOffice 2024-04-01 2025-03-31 04172089 bus:Director2 2024-04-01 2025-03-31 04172089 bus:Director3 2024-04-01 2025-03-31 04172089 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 04172089 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04172089 bus:Agent1 2024-04-01 2025-03-31 04172089 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 04172089 core:MotorVehicles 2024-04-01 2025-03-31 04172089 core:PlantMachinery 2024-04-01 2025-03-31 04172089 countries:England 2024-04-01 2025-03-31 04172089 2024-03-31 04172089 core:FurnitureFittingsToolsEquipment 2024-03-31 04172089 core:MotorVehicles 2024-03-31 04172089 2023-04-01 2024-03-31 04172089 2024-03-31 04172089 bus:OrdinaryShareClass1 2024-03-31 04172089 core:RetainedEarningsAccumulatedLosses 2024-03-31 04172089 core:ShareCapital 2024-03-31 04172089 core:CurrentFinancialInstruments 2024-03-31 04172089 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04172089 core:FurnitureFittingsToolsEquipment 2024-03-31 04172089 core:MotorVehicles 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04172089

Impact Medical Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Impact Medical Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

Impact Medical Limited

Company Information

Directors

Mr Allan Frederick Joy

Mr David Kevin Jones

Registered office

Unit 7J
Topham Drive
Aintree Racecourse Business Park
Liverpool
L9 5AL

Accountants

Phil Owen & Co Limited
Chartered Accountant22 Pall Mall
Liverpool
Merseyside
L3 6AL

 

Impact Medical Limited

(Registration number: 04172089)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

15,476

1,447

Current assets

 

Debtors

5

212,085

203,621

Cash at bank and in hand

 

188,647

131,097

 

400,732

334,718

Creditors: Amounts falling due within one year

6

(101,259)

(140,520)

Net current assets

 

299,473

194,198

Net assets

 

314,949

195,645

Capital and reserves

 

Called up share capital

7

5,000

5,000

Retained earnings

309,949

190,645

Shareholders' funds

 

314,949

195,645

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 July 2025 and signed on its behalf by:
 

.........................................
Mr Allan Frederick Joy
Director

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit 7J
Topham Drive
Aintree Racecourse Business Park
Liverpool
L9 5AL

These financial statements were authorised for issue by the Board on 16 July 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets over their estimated useful lives or if held under a finance lease,over the lease term,whichever is the shorter.

Asset class

Depreciation method and rate

Plant and machinery

25% on cost and 20% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2024 - 11).

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2024

1,232,539

125,652

1,358,191

Additions

2,620

16,725

19,345

At 31 March 2025

1,235,159

142,377

1,377,536

Depreciation

At 1 April 2024

1,231,091

125,652

1,356,743

Charge for the year

1,972

3,345

5,317

At 31 March 2025

1,233,063

128,997

1,362,060

Carrying amount

At 31 March 2025

2,096

13,380

15,476

At 31 March 2024

1,447

-

1,447

5

Debtors

Current

2025
£

2024
£

Trade debtors

175,145

150,322

Prepayments

11,560

11,560

Other debtors

25,380

41,739

 

212,085

203,621

6

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Trade creditors

43,874

52,560

Taxation and social security

37,847

29,577

Accruals and deferred income

-

39,680

Other creditors

19,538

18,703

101,259

140,520

 

Impact Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Creditors: amounts falling due after more than one year

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary Shares of £1 each

5,000

5,000

5,000

5,000

       

8

Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

2025
£

2024
£

Remuneration

183,495

221,179